Ministry of Health, Labour and Welfare– tag –
-
BIANCA CLINIC Pioneers Regenerative Medicine in Japan with Autologous Adipose Stem Cells and Exosome Therapy under Strict Regulatory Compliance
BIANCA CLINIC Japan Overview BIANCA CLINIC in Tokyo is advancing regenerative medicine by offering exosome therapy, purified stem cell culture supernatant, and autologous adipose-derived stem cell therapy, all strictly compliant with Jap... -
Japan Leads Global Stem Cell Research, Excels in Treatment Costs, Methods, and Safety
PlacidWay Japan Overview A PlacidWay infographic report highlights Japan as a global leader in regenerative medicine research, emphasizing its highly structured regulatory environment for stem cell therapy. Japan is particularly well-sui... -
Japan’s Stem Cell Therapy Landscape: High Costs and Strict MHLW Regulations Govern Regenerative Medicine Hubs
PlacidWay Japan Overview Leading stem cell therapy clinics in Japan, such as Cell Grand Clinic and Clinique Haru Osaka Umeda, offer regenerative medicine for conditions like joint disorders, musculoskeletal diseases, diabetes, and Parkin... -
Japan Establishes Global Trust and Safety in Stem Cell Therapy Through Rigorous Act on the Safety of Regenerative Medicine (ASRM)
Grand Green Osaka Umekita Clinic Japan Overview Japan has solidified its position as a globally trusted nation for regenerative medicine, including stem cell therapy, through the 2014 Act on the Safety of Regenerative Medicine (ASRM). Th... -
Japan Grants World’s First Conditional Approval to iPSC-Based Parkinson’s and Heart Failure Therapies, ‘Amchepry’ and ‘RiHEART’
PMDA Regulatory Insights (Facebook) Japan Overview Japan's Ministry of Health, Labour and Welfare granted the world's first conditional approval in early 2026 to two iPSC-based regenerative medicine products: 'Amchepry' for Parkinson's d... -
Japan’s Regenerative Medicine Regulated by Two Pillars: Approved Cell Products and Registered Private Treatments, Emphasizing Safety and Quality
Stem Cell Clarity Japan Overview Japanese regenerative medicine is governed by two distinct legal frameworks: cell products approved by the Minister of Health, Labour and Welfare, and private treatments under a registration system where ... -
Japan Establishes Rigorous Regulatory Framework for Stem Cell and Regenerative Medicine under ASRM
PlacidWay Japan Overview Japan has implemented a stringent regulatory framework for stem cell therapy and regenerative medicine, based on the Act on the Safety of Regenerative Medicine (ASRM). The Ministry of Health, Labour and Welfare (... -
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stemchymal® Stem Cell Therapy for Spinocerebellar Ataxia (SCA3 and SCA6)
BioSpace Japan Overview REPROCELL Inc. has submitted an application for manufacturing and marketing approval in Japan for its regenerative medicine product, Stemchymal®, aimed at inhibiting the progression of motor ataxia in patients wit...
1